Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-02

Clinical Trial Update: Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating fenofibrate in patients with Primary Biliary Cholangitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis | Phase 2, Phase 3 | Status: RECRUITING